Personalized rate control treatment for atrial fibrillation: a prospective case-control study on the use of diltiazem

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Recent ESC Atrial Fibrillation guidelines introduced some changes in the options for rate control, such as the possibility to combine beta-blockers (BB) and non-dihydropyridine calcium channel blockers (NDCC), to address the need o...

Descripción completa

Detalles Bibliográficos
Autores principales: Spadotto, A, Massaro, G, Amadori, M, Damaschin, L, Martignani, C, Ziacchi, M, Biffi, M, Galie, N, Boriani, G, Diemberger, I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
10.4.2 - Rate Control
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206795/
http://dx.doi.org/10.1093/europace/euad122.070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206795/
http://dx.doi.org/10.1093/europace/euad122.070

Ejemplares similares